Bibliographic Details
| Title: |
Randomised controlled trial of continued intravenous versus switching to subcutaneous infliximab in inflammatory bowel disease: the Subcutaneous Infliximab Switch Study (SISS). |
| Authors: |
Chetwood, J.1,2, Redmond, D.1, Kermeen, M.1, Kariyawasam, V.1, Thin, L.3, Lightowler, D.4, Corte, C.4, Ding, N. J. S.5, Ward, M. G.6, Little, R.7, Kwan, V.8, De Cruz, P.9, Lee, L. H.10, Duong, T. A.10, Lee, E.11, Menon, S.12, Khaing, M. M.13, Beswick, L.14, Lagumbay, L.14, Walker, T.15 |
| Source: |
Journal of Crohn's & Colitis. 2026 Supplement, Vol. 20, pi2630-i2632. 3p. |
| Database: |
Academic Search Ultimate |
